《基质生物学》(创建于1980年,前身为《胶原蛋白及其相关研究》)是一本致力于发表基质生物学研究最新成果的前沿期刊。我们欢迎与理解细胞外基质的细胞和分子病理生理学相关的文章。矩阵生物学专注于解决难以捉摸的问题,开辟新的思路和发现途径,挑战长期存在的生物学范式。考虑评审并最终发表的论文,必须包含与重要生理或病理过程相关的力学和功能见解支持的实质性进展。这些方面是至关重要的,是出版所必需的。矩阵生物学欢迎原创的研究文章,简短的报告,评论,(迷你)评论和公告。更多信息请查看我们的作者指南。向矩阵生物学提交下一篇文章的理由:矩阵生物学的第一杂志;发表的文章对全世界的研究人员具有普遍的吸引力、价值和实用价值。高影响度量:在左侧列中找到当前度量。该领域的关键研究人员组成的国际委员会。严格、公平、高效的同行评审流程。你的论文你的方式:没有不必要的格式要求。灵活发布:您可以选择发布开放访问。快速出版:您的文章可在接受后一周内在线。在线版本不收页面费和颜色费。选择联合提交数据文章到数据简要。
Matrix Biology (established in 1980 as Collagen and Related Research) is a cutting-edge journal that is devoted to publishing the latest results in matrix biology research. We welcome articles that reside at the nexus of understanding the cellular and molecular pathophysiology of the extracellular matrix. Matrix Biology focusses on solving elusive questions, opening new avenues of thought and discovery, and challenging longstanding biological paradigms.Papers considered for review, and ultimately for publication, must contain substantial advances supported by mechanistic and functional insights germane to important physiological or pathological processes. These aspects are crucial and required for publication.Matrix Biology welcomes original research articles, brief reports, commentaries, (mini) reviews, and announcements. Please view our Guide for Authors for more information.Reasons to submit your next article to Matrix Biology:The premier journal in matrix biology; published articles have a universal appeal, value, and utility to the researcher community worldwide.High impact metrics: find our current metrics in the left-hand column.An international board of key researchers in the field.Rigorous, fair and efficient peer review process.Your paper your way: no unnecessary formatting requests.Flexible publication: you can choose to publish open access.Rapid publication: your article available online within a week after acceptance.No page charges and no color charges for online version.Option of co-submitting a data article to Data in Brief.
SCI热门推荐期刊 >
SCI常见问题 >
职称论文常见问题 >
EI常见问题 >